Physician profile
James Francis Kane, III
NPI 1659388445
$929.49
in general payments reported to CMS, 2019-2025
7 companies · $433 in 2025
The $433 reported for 2025 was more than what 78% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.83 · 2020: $21.14 · 2022: $142 · 2023: $184 · 2024: $53.43 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427 · Education: $200 · Consulting Fee: $35.00 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.72 |
| Education | $200.00 |
| Consulting Fee | $35.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $712.48 | 2019-2025 | Invisalign, Invisalign Touch Up, Invisalign Express 10 |
| American Orthodontics Corporation | $91.76 | 2023 | Lp and Ifit Tubes, Radiance, Empower-Ceramic |
| Scican INC | $41.60 | 2019 | |
| Envista Holdings Corporation | $31.28 | 2025 | Titanium Orthos |
| Ortho Organizers, INC. | $21.14 | 2020 | |
| 3m Company | $17.83 | 2019 | |
| Henry Schein, INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.